A Psychoanalytic Perspective on Psychedelic Experience
This perspective (2022) provides an understanding of the psychedelic experience through 1) ego dissolution and mystical states, 2) hyperassociative states, and 3) the role of set and setting.
Abstract
As interest in psychedelics as treatments for psychological problems grows, it is important for psychoanalysts to learn about them. Our patients will come to us to discuss their psychedelic experiences; additionally, psychedelics deserve reconsideration as meaningful collaborators with our field, at both the theoretical and clinical levels. After a brief history of these agents, the paper engages three specific areas: 1) psychedelics’ capacity to evoke egolysis, or ego dissolution, and mystical states; 2) their capacity to support hyperassociative states, free association, and emergence of unconscious material, and 3) the role of set and setting in psychedelic therapy. Drawing from the fields of neuropsychoanalysis, phenomenological research and neuroanthropology, the paper offers a discourse that connects mind and brain and psychedelics in ways meaningful for psychoanalysts.
Research Summary of 'A Psychoanalytic Perspective on Psychedelic Experience'
Introduction
Guss situates the paper within the renewed, multidisciplinary interest in psychedelics over the past three decades and argues that psychoanalysis is particularly well placed to engage with this revival. The Introduction outlines how psychedelics uniquely affect consciousness, perception, identity and meaning-making and emphasises that intentions for use and contextual factors are central to understanding psychedelic effects. Guss proposes a rapprochement between psychoanalytic theory and psychedelic practice, suggesting each can inform and deepen the other. The author explains that the paper will first canvass historical and cross-cultural uses of psychedelic substances, then focus on two core phenomena that are of primary relevance to psychoanalysts: ego dissolution (egolysis) and unconstrained, hyperassociative cognition. Through a synthesis of neuropsychoanalysis, phenomenology and neuroanthropology, the paper aims to connect brain-based findings with psychoanalytic concepts and to show how psychoanalytic settings and skills can be valuable in psychedelic therapy.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Full Text PDF
Full Paper PDF
Create a free account to open full-text PDFs.
Study Details
- Study Typemeta
- Journal
- Topics
- Author
- APA Citation
Guss, J. (2022). A Psychoanalytic Perspective on Psychedelic Experience. Psychoanalytic Dialogues, 32(5), 452-468. https://doi.org/10.1080/10481885.2022.2106140
References (22)
Papers cited by this study that are also in Blossom
Belser, A. B., Agin-Liebes, G. I., Swift, T. C. et al. · Journal of Humanistic Psychology (2017)
Bouso, J. C., González, D., Fondevila, S. et al. · PLOS ONE (2012)
Carhart-Harris, R. L., Erritzoe, D., Williams, T. et al. · PNAS (2012)
Carhart-Harris, R. L., Friston, K. J. · Brain (2010)
Carhart-Harris, R. L., Friston, K. J. · Pharmacological Reviews (2019)
Carhart-Harris, R. L., Goodwin, G. M. · Neuropsychopharmacology (2017)
Carhart-Harris, R. L., Leech, R., Shanahan, M. et al. · Frontiers in Human Neuroscience (2014)
Frecska, E., Móré, C. E., Vargha, A. et al. · Journal of Psychoactive Drugs (2012)
Gashi, L., Sandberg, S., Pedersen, W. · International Journal of Drug Policy (2021)
Harman, W. W., McKim, R. H., Mogar, R. E. et al. · Psychological Reports (1966)
Show all 22 referencesShow fewer
Hartogsohn, I. · Drug Science Policy and Law (2017)
Johnson, M. W., Hendricks, P. S., Barrett, F. S. et al. · Pharmacology and Therapeutics (2019)
Johnson, M. W., Richards, W. A., Griffiths, R. R. · Journal of Psychopharmacology (2008)
Moreno, F. A., Wiegand, C. B., Taitano, E. K. et al. · Journal of Clinical Psychiatry (2006)
Nichols, D. E. · Pharmacological Reviews (2016)
Nour, M. R., Carhart-Harris, R. L. · British Journal of Psychiatry (2017)
Nour, M. R., Evans, J., Nutt, D. J. et al. · Frontiers in Human Neuroscience (2016)
Palhano-Fontes, F., Andrade, K. C., Tófoli, L.F. et al. · PLOS ONE (2015)
Pink-Hashkes, S., Van Rooij, I., Kwisthout, J. · CogSci (2017)
Rucker, J., Iliff, J., Nutt, D. J. · Neuropharmacology (2017)
Schenberg, E. E. · Frontiers in Pharmacology (2018)
Swanson, L. R. · Frontiers in Pharmacology (2018)
Cited By (2)
Papers in Blossom that reference this study
Buchborn, T., Kettner, H., Kartner, L. et al. · Frontiers in Neuroscience (2023)
Ponomarenko, P., Seragnoli, F., Calder, A. et al. · Journal of Psychopharmacology (2023)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.